gSage TM is an AI-native Precision Oncology Platform.
Our next-generation data and AI infrastructure powers gSage CancerOS.
It turns a patient’s multi-modal information into one AI-ready longitudinal record, simulates therapy response, and learns from every outcome.
Population risk and early detection
Multimodal and
quantitative
Tissue sampling and minimally invasive diagnosis
Morphology,
subtype and
prognostic markers
Genomic, transcriptomic
and other biomarkers
Personalized and
multidisciplinary
care
Tumor response
and mInimum
residual disease monitoring
GeneSilico’s integrated reports provide significantly deeper and more actionable treatment insights compared with interpreting individual diagnostic reports in isolation.
They help me make more informed, personalized, and comprehensive treatment decisions for my cancer patients.
This technology helps us to guide the further treatment so that we can avoid the unnecessary toxicities of medicines, and we can give what medicine is most likely in the given patient.
We have used it.
We are convinced with the results.
Casebook is the longitudinal, multimodal patient record, built at the point of care and reasoned over by specialist agents.
use it for clinical decision support.
use our platform’s de-identified patient data for intelligent cohort selection based on molecular level matching through our gSage Digital Twin simulation.
One longitudinal patient record. Two products.
+6.5M
longitudinal patient records
feeding the gSage data flywheel for training and validation
in a registered clinical study
in a registered clinical study
in a registered clinical study
Live with hundreds of oncologists. Ready for your institution.
